Caroline O. Michie

Germline Mutation in <i>BRCA1</i> or <i>BRCA2</i> and Ten-Year Survival for Women Diagnosed with Epithelial Ovarian Cancer

Francisco José Cândido dos Reis, Honglin Song, Ellen L. Goode et al. · Clinical Cancer Research · 2014 · 158 citations · Full text

Molecular subgroup of high-grade serous ovarian cancer (HGSOC) as a predictor of outcome following bevacizumab.

Charlie Gourley, Andrena McCavigan, Timothy Perren et al. · Journal of Clinical Oncology · 2014 · 123 citations

Does shear wave ultrasound independently predict axillary lymph node metastasis in women with invasive breast cancer?

Andrew Evans, Petra Rauchhaus, Kim Thomson et al. · Breast Cancer Research and Treatment · 2013 · 109 citations · Full text

Expression of glycolytic enzymes in ovarian cancers and evaluation of the glycolytic pathway as a strategy for ovarian cancer treatment

Chrysi Xintaropoulou, Carol Ward, Alan Wise et al. · BMC Cancer · 2018 · 102 citations · Full text

Increased Incidence of Visceral Metastases in Scottish Patients With BRCA1/2-Defective Ovarian Cancer: An Extension of the Ovarian BRCAness Phenotype

Charlie Gourley, Caroline O. Michie, Patricia Roxburgh et al. · Journal of Clinical Oncology · 2010 · 91 citations